BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22658439)

  • 21. [Recurrence of gynecologic malignancies after combined and primary radiotherapy. Incidence and lapse of time until the diagnosis is made].
    Csaicsich P; Tatra G; Michalica W
    Strahlenther Onkol; 1986 Jul; 162(7):409-13. PubMed ID: 3738739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gynecological cancer in the Maltese Islands.
    Sultana HM; Camilleri AP
    Gynecol Oncol; 1977 Dec; 5(4):346-56. PubMed ID: 590856
    [No Abstract]   [Full Text] [Related]  

  • 23. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The gynecological implant patient.
    Shell JA; Carter J
    Semin Oncol Nurs; 1987 Feb; 3(1):54-66. PubMed ID: 3645698
    [No Abstract]   [Full Text] [Related]  

  • 25. Brachytherapy in Gynecologic Cancers: Why Is It Underused?
    Han K; Viswanathan AN
    Curr Oncol Rep; 2016 Apr; 18(4):26. PubMed ID: 26940059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level.
    Yamazaki H; Inoue T; Tanaka E; Isohashi F; Koizumi M; Shuo X; Nakamura H; Inoue T
    Radiat Med; 2005 Aug; 23(5):317-21. PubMed ID: 16342902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of the gynecologic cancers.
    Cramer DW
    Compr Ther; 1978 Mar; 4(3):9-17. PubMed ID: 630831
    [No Abstract]   [Full Text] [Related]  

  • 30. Quality assurance of multifractionated pelvic interstitial brachytherapy for postoperative recurrences of cervical cancers: a prospective study.
    Shukla P; Chopra S; Engineer R; Mahantshetty U; Paul SN; Phurailatpam R; SV J; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e617-22. PubMed ID: 22300566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy for gynecologic cancer.
    Tewari KS; DiSaia PJ
    J Obstet Gynaecol Res; 2002 Jun; 28(3):123-40. PubMed ID: 12214828
    [No Abstract]   [Full Text] [Related]  

  • 32. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
    Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
    Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience report on 40 years of radiotherapy in approximately 1,300 gynecological cases].
    Alth G
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:219. PubMed ID: 4367066
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indication for radiotherapy in gynecologic malignomas].
    Pfeiffer J; Schuhknecht HJ; Röder K
    Z Arztl Fortbild (Jena); 1973 Sep; 67(17):856-61. PubMed ID: 4588423
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ozone-oxygen injection in gynecological radiotherapy].
    Hernuss P; Müller-Tyl E; Dimopoulos J
    Strahlentherapie; 1974 Sep; 148(3):242-5. PubMed ID: 4446040
    [No Abstract]   [Full Text] [Related]  

  • 37. Resource utilization. High dose rate versus low dose rate brachytherapy for gynecologic cancer.
    Bastin K; Buchler D; Stitt J; Shanahan T; Pola Y; Paliwal B; Kinsella T
    Am J Clin Oncol; 1993 Jun; 16(3):256-63. PubMed ID: 8338060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study.
    Eifel PJ; Moughan J; Erickson B; Iarocci T; Grant D; Owen J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1144-53. PubMed ID: 15519786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of the incidence of female genital cancer in Tomsk Province].
    Rybnikov VI
    Vopr Onkol; 1986; 32(6):28-33. PubMed ID: 3727480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.